Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Vascular
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subject is an acceptable candidate for treatment with a drug-eluting stent in accordance with the applicable guidelines on percutaneous coronary interventions, the Instructions for Use of the Resolute Integrity 34/38 mm stent
The subject can have either a single lesion, or two lesions located in separate target vessels treated during the index procedure. Each lesion length needs to be ≤35mm with at least one lesion length \>27mm and≤ 35mm and amenable for treatment with a Resolute Integrity 34/38 mm stent
You may not be if
STEMI within 24 hours
Left main disease
Bifurcation disease
Clareo Health | China Resolute Integrity 34/38 mm Study
